| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| H-B-Vax II Paediatric preservative free 5 microgram/0.5 mL injection suspension, 10 x 0.5 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Alphapharm) 50 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Pharmacor) 100 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Engerix-B Paediatric 10 microgram/0.5 mL injection suspension, 0.5 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (SZ) 100 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Actavis) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Eloxatin 200 mg/40 mL injection, 40 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Alphapharm) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Engerix-B Adult 20 microgram/mL injection suspension, 10 x 1 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (DBL) (oxaliplatin 20 mg) powder for injection, 1 x 20 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Engerix-B Paediatric 10 microgram/0.5 mL injection suspension, 25 x 0.5 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Oxalatin 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Eloxatin (oxaliplatin 50 mg / 10 mL) injection, 1 x 10 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| H-B-Vax II preservative free 10 microgram/mL injection suspension, 1 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Eloxatin 100 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Engerix-B Paediatric 10 microgram/0.5 mL injection suspension, 10 x 0.5 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Actavis) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (DBL) 50 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (AS) 50 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Alphapharm) 50 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Link Medical Products) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Winthrop) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Baxter) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplan (oxaliplatin 50 mg) powder for injection, 1 x 50 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliccord 50 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxalatin 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oxaliplatin (Alphapharm) 50 mg powder for injection, 3 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Colistin (Link) 150 mg powder for injection, 1 vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Tadim 1 million units (80 mg) powder for inhalation, 30 vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Emend IV 115 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Granisetron (Sandoz) 1 mg/mL injection: concentrated, 5 x 1 mL vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Granisetron (Sandoz) 3 mg/3 mL injection: concentrated, 3 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Chloromycetin Succinate (chloramphenicol 1 g) powder for injection, 1 x 1 g vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Benpen 600 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Benpen 3 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Benpen 1.2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Zaltrap 200 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Polio Sabin Multidose oral liquid: solution, 100 vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Eylea 2 mg/0.05 mL injection: solution, 0.05 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Sodium Nitrite (Phebra) 300 mg/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Zaltrap (aflibercept 100 mg / 4 mL) injection, 1 x 4 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Zinc Sulphate (Phebra) 50 mg/mL injection, 10 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Apidra 100 units/mL injection, 1 x 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Charcotrace 120 mg/3 mL injection, 10 x 3 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (Kabi) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (Sandoz) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Botox 100 units injection: powder for, 1 vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Meropenem (Kabi) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Merrem IV 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (Sandoz) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (Kabi) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (Kabi) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (Sandoz) 20 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Merrem IV 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oncotaxel 140 mg/7 mL injection, 7 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (Sandoz) 80 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (DBL) 160 mg/16 mL injection, 16 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (DBL) 20 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oncotaxel 20 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Taxotere 80 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Remodulin 100 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (Dakota) 80 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Remodulin 20 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Oncotaxel 80 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Remodulin 200 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (Dakota) 20 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Remodulin 50 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (DBL) 80 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Taxotere 20 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (Ebewe) 20 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Docetaxel (Ebewe) 80 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Tubersol 50 tuberculin units/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| L-Arginine Hydrochloride (Phebra) 60% (15 g/25 mL) injection, 10 x 25 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Cubicin 350 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Cubicin 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Plaxel 300 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Humulin NPH Isophane 100 units/mL injection, 1 x 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (GN) 30 mg/5 mL injection: solution, 5 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Gadovist-1.0 9.07 g/15 mL injection, 10 x 15 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Lucassin 850 microgram powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Protaphane 100 units/mL injection, 1 x 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Ebewe) 30 mg/5 mL injection, 5 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Daunorubicin (Pfizer (Perth)) 20 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Lucassin 850 microgram powder for injection, 12 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Ebewe) 100 mg/16.7 mL injection, 16.7 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Kabi) 30 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Ebewe) 150 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (GN) 300 mg/50 mL injection: solution, 50 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (DP) 300 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Actavis) 30 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Actavis) 150 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Actavis) 300 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Plaxel 100 mg/16.7 mL injection: concentrated, 16.7 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Taxol 100 mg/16.7 mL injection, 16.7 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexamethasone Phosphate (DBL) 120 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Baxter) 30 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Kabi) 100 mg/16.7 mL injection, 16.7 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmethsone 8 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|